The Company anticipates a response from the FDA for the approval of the feeding trial design in approximately 45 days TORONTO, Aug. 8, 2024 /PRNewswire/ – CULT Food Science Corp. (“CULT” or the “Company”) (CSE: CULT) (OTC: CULTF) (FRA: LN00), a disruptive food technology platform…